Search results for "From Annals of Internal Medicine"
Case report of DKA from a gout flare
A recently published case described a patient with a history of tophaceous gout who developed diabetic ketoacidosis (DKA) during a severe acute polyarticular gout flare.
https://diabetes.acponline.org/archives/2024/09/13/9.htm
13 Sep 2024
Case reports of patients with diabetes
One recent case report described bullous pemphigoid while another described black esophagus.
https://diabetes.acponline.org/archives/2024/12/13/10.htm
13 Dec 2024
Latest Beyond the Guidelines, In the Clinic target diabetes
An endocrinologist and a nephrologist discuss appropriate care for type 2 diabetes and chronic kidney disease, and the evidence supporting type 2 diabetes prevention and treatment are reviewed.
https://diabetes.acponline.org/archives/2024/06/14/6.htm
14 Jun 2024
Medicare coverage of semaglutide would be costly
Covering semaglutide for patients who are overweight and have cardiovascular disease could cost Medicare an additional $34 to $145 billion annually, researchers estimated.
https://diabetes.acponline.org/archives/2024/09/13/7.htm
13 Sep 2024
In the Clinic, Ideas and Opinions address diabetes
A recent In the Clinic reviewed hyperglycemia in hospitalized patients, and an opinion article discussed misuse of race in interpretation of HbA1c levels.
https://diabetes.acponline.org/archives/2024/12/13/8.htm
13 Dec 2024
Little difference in dementia risk with SGLT-2s vs. dulaglutide
Older patients with type 2 diabetes starting sodium-glucose cotransporter-2 (SGLT-2) inhibitors had an estimated difference of less than a percentage point in five-year risk of clinical onset of dementia compared with those starting the glucagon-like peptide-1 receptor agonist dulaglutide, a South Korean study found.
https://diabetes.acponline.org/archives/2024/09/13/6.htm
13 Sep 2024
Two case reports describe complications in patients with diabetes
One case report described a type 1 diabetes patient with disseminated mucormycosis with rhinocerebral and pulmonary involvement, while the other reported a case of euglycemic diabetic ketoacidosis related to semaglutide.
https://diabetes.acponline.org/archives/2024/06/14/10.htm
14 Jun 2024
SGLT-2 inhibitors associated with improved outcomes in stage 5 CKD patients
Patients with type 2 diabetes and stage 5 chronic kidney disease (CKD) had lower risk of progressing to dialysis or having a cardiovascular event if they took sodium-glucose cotransporter-2 (SGLT-2) inhibitors, a study found.
https://diabetes.acponline.org/archives/2024/05/10/6.htm
10 May 2024
Case reports describe unusual occurrences in patients with diabetes
Recent case reports focused on linagliptin-induced pancreatitis and euglycemic diabetic ketoacidosis after cardiac surgery.
https://diabetes.acponline.org/archives/2023/10/13/8.htm
13 Oct 2023
Use of GLP-1 receptor agonists rose steeply in past decade, study finds
A million U.S. patients, mostly women, started taking glucagon-like peptide-1 (GLP-1) receptor agonists between 2011 and 2023, according to an analysis of medical records across the country.
https://diabetes.acponline.org/archives/2024/08/09/6.htm
9 Aug 2024